ArticleFrontiers in immunology2026

Patient-derived organoids guide personalized therapy for KRAS-mutant pancreatic cancer: synergistic MEK/mTOR inhibition and predictive chemotherapy responses.

Xiaorui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.